| Literature DB >> 25554827 |
Min Luo1, Kent S Gates1, Michael T Henzl2, John J Tanner1,2.
Abstract
There is growing interest in aldehyde dehydrogenases (ALDHs) because of their overexpression in cancer stem cells and the ability to mediate resistance to cancer drugs. Here, we report the first crystal structure of an aldehyde dehydrogenase complexed with the inhibitor 4-diethylaminobenzaldehyde (DEAB). Contrary to the widely held belief that DEAB is a reversible inhibitor of ALDHs, we show that DEAB irreversibly inactivates ALDH7A1 via formation of a stable, covalent acyl-enzyme species.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25554827 DOI: 10.1021/cb500977q
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100